Dr Alastair Greystoke is a Consultant Medical Oncologist, Northern Centre for Cancer Care; and Clinical Senior Lecturer, Newcastle University; Newcastle upon Tyne, UK.
Dr Greystoke’s areas of interests include: development and application of novel therapeutics and personalised medicine in lung cancer, circulating biomarkers, and treatment of cancer in the elderly. He works extensively with the Sir Bobby Robson Clinical Trials Unit at the Freeman Hospital, Newcastle upon Tyne; and has authorship on numerous publications in NSCLC in such areas as: clinical trials for personalised and targeted therapies (e.g., EGFR TKIs), radical therapy for NSCLC, and immunotherapy in older patients.
Additionally, Dr Greystoke serves as Joint Clinical Investigator of the CONCORDE platform; Clinical Lead for Cancer for the Yorkshire, Hull, and North East England Genomic Laboratory Hub; and Lead for the Pharmacodynamic Biomarker Team at the Centre for Cancer Research, Newcastle University, Newcastle upon Tyne.
EM-92640 - Date of preparation: March 2022